AstraZeneca to buy Amolyt Pharma for US$1.05 billion to boost rare-disease portfolio
DRUGMAKER AstraZeneca said on Thursday (Mar 14) it would acquire rare endocrine diseases-focused firm Amolyt Pharma for US$1.05 billion in ...
Tag: Pharma
Nikkei secures all-time closing high as pharma excels
JAPAN’S Nikkei share average scaled to record highs for the second consecutive session on Monday (Feb 26), supported by upbeat ...
2 Pharma Stocks to Buy Right Now and 1 You Might Want to Consider Selling | Entrepreneur
The pharmaceutical industry is evolving with personalized medicines and the rapid adoption of RPM technology, which should boost growth. Moreover, ...
How Green Pharma Can Cure Disease and Save the Planet
Opinions expressed by Entrepreneur contributors are their own. As managing climate change is becoming an increasingly urgent issue, the demand ...
Forbes 40under40 stands as a distinguished platform revered for its commitment to honoring and applauding the remarkable achievements of exceptional individuals who have yet to reach the age of 40. This esteemed initiative serves as a beacon of inspiration, spotlighting trailblazers across various industries and domains, showcasing their innovation, leadership, and impact on a global scale.
© 2025 Forbes 40under40. All Rights Reserved.